Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pathogens (Basel, Switzerland)|June 9, 2017
Modeling HSV-1 Latency in Human Embryonic Stem Cell-Derived NeuronsAldo Pourchet, Aram S Modrek, Dimitris G Placantonakis, et al.
Virology|September 29, 2017
Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63Aldo Pourchet, Richard Copin, Matthew C Mulvey, et al.
Molecular Therapy Oncolytics|June 12, 2018
Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic VirusHannah M Burgess, Aldo Pourchet, Cristina H Hajdu, et al.
Ebiomedicine|April 15, 2016
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus ImmunotherapyAldo Pourchet, Steven R Fuhrmann, Karsten A Pilones, et al.
Veterinary Microbiology|December 3, 2005
Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotypeBenoît Muylkens, François Meurens, Frédéric Schynts, et al.
The Journal of General Virology|July 19, 2006
Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattleBenoît Muylkens, François Meurens, Frédéric Schynts, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancerRafaela Argnani, Peggy Marconi, Ilaria Volpi, et al.
The Journal of Gene Medicine|November 25, 2010
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectorsPelagia Foka, Aldo Pourchet, Ruben Hernandez-Alcoceba, et al.
Pageof 1